Posters

Evaluation of a rotational-assymetric multifocale intraocular lens with a standard toricity and a +1.5 D near addition

Poster Details

First Author: F.Kretz GERMANY

Co Author(s):    H. Kaymak   R. Gerl   M. Müller   G. Auffarth   M. Gerl   D. Breyer

Abstract Details

Purpose:

Clinical evaluation of a rotational-assymetric multifocale intraocular lens with a standard toricity and a +1.5 D near addition for the correction of presbyopia and astigmatism during cataract surgery.

Setting:

International Vision Correction Research Network (IVCRC.net) & Dr. Gerl & colleagues, Ahaus Germany

Methods:

In a prospective multicenter study patients patients that underwent cataract surgery with a corneal astigmatism ≥ 0.75 D receives a rotational-assymetric multifocale intraocular lens with a standard toricity and a +1.5 D near addition (LS-313MF15 T1-T6, Oculentis, Germany). The preoperative biometry was performed with the IOL-Master 700 (Carl Zeiss Meditech, Germany). Subjective refraction, corrected and uncorrected visual acuity, monocular and binocular [decimal] for distance, intermediate and near as well as binocular defocus curve analysis and rotational stability were evaluated.

Results:

A significant reduction of astigmatismi from -1.36 D to -0,25 D could be found. The mean postoperative monocular UDVA was 1.06, the UIVA was 1.02 and the UNVA was 0.51, respectively. Mean IOL rotation was 1.6°.

Conclusions:

Rotational-assymetric multifocale intraocular lenses with a standard toricity and a +1.5 D near addition based on a plate haptic design show an excellent rotational stability and sufficient astigmatism correction even for small grades of astigmatism. The evaluated +1.5 D near addition MIOL shows his benefits for distance and intermediate visual acuity while still offering acceptable near visual acuity. FINANCIAL DISCLOUSRE: One or more of the authors receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, One or more of the authors travel has been funded, fully or partially, by a competing company, One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One or more of the authors research is funded, fully or partially, by a competing company, One or more of the authors research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One or more of the authors receives consulting fees, retainer, or contract payments from a competing company